COMP <GO>
AEHR vs SO // REVENUE GROWTH (YOY)
Aehr Test Systems (NASDAQ) VS. Southern Company (The) (NYSE) • 15-METRIC TALLY: AEHR 4
— SO 10
▲ REVENUE GROWTH (YOY) LEADER: SO
LAST: $54.89 (-10.33%) • MKT CAP: $2.00B
revenue-growth
-15.20%
LAST: $93.71 (+0.77%) • MKT CAP: $106.97B
revenue-growth
10.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AEHR VS. SO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AEHR | SO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.30% | 41.00% | -5.70 | SO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -7.00% | 6.90% | -13.90 | SO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 8.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.27% | -2.74% | +2.47 | AEHR | /fcf-yield <GO> |
| Operating Margin | -28.30% | 24.70% | -53.00 | SO | /operating-margins <GO> |
| Net Profit Margin | -14.30% | 14.70% | -29.00 | SO | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -15.20% | 10.60% | -25.80 | SO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.40% | 2.82% | +0.58 | AEHR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 0.98 | +25.02 | AEHR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 5/9 | -1.00 | SO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.10% | 5.50% | +0.60 | SO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.5 | 66.6 | -34.11 | SO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.76 | 0.58 | +0.18 | AEHR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.0x | 22.9x | +10.10 | SO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.00B | $106.97B | -$104.97B | SO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AEHR REV | SO REV | AEHR GROSS % | SO GROSS % | AEHR FCF | SO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $50.0M | $29.55B | 35.3% | 44.0% | -$5.4M | -$2.94B |
| FY 2024 | $59.0M | $26.72B | 40.6% | 44.0% | -$12.4M | $833.0M |
| FY 2023 | $66.2M | $25.25B | 44.0% | 44.0% | -$1.2M | $6.42B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AEHR // BETA 0.76
SO // BETA 0.58